In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1791991). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 829 of the RET protein (p.Ser829Asn).
ClinVar Genomic variation as it relates to human health
NM_020975.6(RET):c.2486G>A (p.Ser829Asn)
Germline
Classification
Help
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
(2)
Help
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance
2
criteria provided, multiple submitters, no conflicts
Somatic
No data submitted for somatic clinical impact
Somatic
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_020975.6(RET):c.2486G>A (p.Ser829Asn)
Variation ID: 1791991 Accession: VCV001791991.6
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 10q11.21 10: 43119624 (GRCh38) [ NCBI UCSC ] 10: 43615072 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Nov 29, 2022 Aug 11, 2024 Mar 22, 2024 - HGVS
-
... more HGVS ... less HGVSNucleotide Protein Molecular
consequenceNM_020975.6:c.2486G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_066124.1:p.Ser829Asn missense NM_000323.2:c.2486G>A NP_000314.1:p.Ser829Asn missense NM_001355216.2:c.1724G>A NP_001342145.1:p.Ser575Asn missense NM_001406743.1:c.2486G>A NP_001393672.1:p.Ser829Asn missense NM_001406744.1:c.2486G>A NP_001393673.1:p.Ser829Asn missense NM_001406759.1:c.2486G>A NP_001393688.1:p.Ser829Asn missense NM_001406760.1:c.2486G>A NP_001393689.1:p.Ser829Asn missense NM_001406761.1:c.2357G>A NP_001393690.1:p.Ser786Asn missense NM_001406762.1:c.2357G>A NP_001393691.1:p.Ser786Asn missense NM_001406763.1:c.2351G>A NP_001393692.1:p.Ser784Asn missense NM_001406764.1:c.2357G>A NP_001393693.1:p.Ser786Asn missense NM_001406765.1:c.2351G>A NP_001393694.1:p.Ser784Asn missense NM_001406766.1:c.2198G>A NP_001393695.1:p.Ser733Asn missense NM_001406767.1:c.2198G>A NP_001393696.1:p.Ser733Asn missense NM_001406768.1:c.2222G>A NP_001393697.1:p.Ser741Asn missense NM_001406769.1:c.2090G>A NP_001393698.1:p.Ser697Asn missense NM_001406770.1:c.2198G>A NP_001393699.1:p.Ser733Asn missense NM_001406771.1:c.2048G>A NP_001393700.1:p.Ser683Asn missense NM_001406772.1:c.2090G>A NP_001393701.1:p.Ser697Asn missense NM_001406773.1:c.2048G>A NP_001393702.1:p.Ser683Asn missense NM_001406774.1:c.1961G>A NP_001393703.1:p.Ser654Asn missense NM_001406775.1:c.1760G>A NP_001393704.1:p.Ser587Asn missense NM_001406776.1:c.1760G>A NP_001393705.1:p.Ser587Asn missense NM_001406777.1:c.1760G>A NP_001393706.1:p.Ser587Asn missense NM_001406778.1:c.1760G>A NP_001393707.1:p.Ser587Asn missense NM_001406779.1:c.1589G>A NP_001393708.1:p.Ser530Asn missense NM_001406780.1:c.1589G>A NP_001393709.1:p.Ser530Asn missense NM_001406781.1:c.1589G>A NP_001393710.1:p.Ser530Asn missense NM_001406782.1:c.1589G>A NP_001393711.1:p.Ser530Asn missense NM_001406783.1:c.1460G>A NP_001393712.1:p.Ser487Asn missense NM_001406784.1:c.1496G>A NP_001393713.1:p.Ser499Asn missense NM_001406785.1:c.1469G>A NP_001393714.1:p.Ser490Asn missense NM_001406786.1:c.1460G>A NP_001393715.1:p.Ser487Asn missense NM_001406787.1:c.1454G>A NP_001393716.1:p.Ser485Asn missense NM_001406788.1:c.1301G>A NP_001393717.1:p.Ser434Asn missense NM_001406789.1:c.1301G>A NP_001393718.1:p.Ser434Asn missense NM_001406790.1:c.1301G>A NP_001393719.1:p.Ser434Asn missense NM_001406791.1:c.1181G>A NP_001393720.1:p.Ser394Asn missense NM_001406792.1:c.1037G>A NP_001393721.1:p.Ser346Asn missense NM_001406793.1:c.1037G>A NP_001393722.1:p.Ser346Asn missense NM_001406794.1:c.1037G>A NP_001393723.1:p.Ser346Asn missense NM_020629.2:c.2486G>A NP_065680.1:p.Ser829Asn missense NM_020630.7:c.2486G>A NP_065681.1:p.Ser829Asn missense NC_000010.11:g.43119624G>A NC_000010.10:g.43615072G>A NG_007489.1:g.47556G>A LRG_518:g.47556G>A LRG_518t1:c.2486G>A LRG_518p1:p.Ser829Asn LRG_518t2:c.2486G>A LRG_518p2:p.Ser829Asn - Protein change
- S394N, S485N, S487N, S575N, S683N, S784N, S499N, S654N, S733N, S434N, S490N, S741N, S829N, S346N, S530N, S587N, S697N, S786N
- Other names
- -
- Canonical SPDI
- NC_000010.11:43119623:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
| Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
|---|---|---|---|---|---|---|
| HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
| RET | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
3595 | 3717 | |
Conditions - Germline
| Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
|---|---|---|---|---|
| Uncertain significance (1) |
criteria provided, single submitter
|
Mar 22, 2024 | RCV002430859.3 | |
| Uncertain significance (1) |
criteria provided, single submitter
|
May 9, 2023 | RCV003101873.4 |
Submissions - Germline
| Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
|---|---|---|---|---|---|
|
Uncertain significance
(May 09, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia, type 2
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003466228.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 20, 2024 |
Comment:
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant … (more)
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1791991). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 829 of the RET protein (p.Ser829Asn). (less)
|
|
|
Uncertain significance
(Mar 22, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002741764.3
First in ClinVar: Nov 29, 2022 Last updated: Aug 11, 2024 |
Comment:
The p.S829N variant (also known as c.2486G>A), located in coding exon 14 of the RET gene, results from a G to A substitution at nucleotide … (more)
The p.S829N variant (also known as c.2486G>A), located in coding exon 14 of the RET gene, results from a G to A substitution at nucleotide position 2486. The serine at codon 829 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. (less)
|
Comment:
Comment:
The p.S829N variant (also known as c.2486G>A), located in coding exon 14 of the RET gene, results from a G to A substitution at nucleotide position 2486. The serine at codon 829 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Germline Functional Evidence
| There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Comment:
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1791991). This variant has not been reported in the literature in individuals affected with RET-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 829 of the RET protein (p.Ser829Asn).
Comment:
The p.S829N variant (also known as c.2486G>A), located in coding exon 14 of the RET gene, results from a G to A substitution at nucleotide position 2486. The serine at codon 829 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Citations for germline classification of this variant
Help| There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.